{"entity":{"type":"insider","cik":"0001344441","url":"/insider/0001344441","json_url":"/insider/0001344441.json","name":"Toucan Partners, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":6,"first":"2014-12-19","last":"2014-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Toucan Partners, LLC","source":"filing","n_filings":6,"first_seen":"2014-12-19","last_seen":"2014-12-22"}],"transactions":[{"id":9236703,"accession":"0001144204-14-075196","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-12","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149502.0,"shares_display":"149,502","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":750500.04,"total_display":"750,500.04","shares_owned_after":20228482.0,"shares_owned_after_display":"20,228,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-12-22","scope":"insider"},{"id":6902771,"accession":"0001144204-14-075189","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-12","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149502.0,"shares_display":"149,502","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":750500.04,"total_display":"750,500.04","shares_owned_after":20228482.0,"shares_owned_after_display":"20,228,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-12-19","scope":"insider"},{"id":9236704,"accession":"0001144204-14-075196","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-11","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":639108.0,"shares_display":"639,108","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":20377984.0,"shares_owned_after_display":"20,377,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902766,"accession":"0001144204-14-075189","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-11","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":639108.0,"shares_display":"639,108","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":20377984.0,"shares_owned_after_display":"20,377,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236699,"accession":"0001144204-14-075196","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-10","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145068.0,"shares_display":"145,068","price_per_share":5.17,"price_display":"5.17","price_state":"stated","total_value":750001.56,"total_display":"750,001.56","shares_owned_after":19738876.0,"shares_owned_after_display":"19,738,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-12-22","scope":"insider"},{"id":6902764,"accession":"0001144204-14-075189","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-10","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145068.0,"shares_display":"145,068","price_per_share":5.17,"price_display":"5.17","price_state":"stated","total_value":750001.56,"total_display":"750,001.56","shares_owned_after":19738876.0,"shares_owned_after_display":"19,738,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-12-19","scope":"insider"},{"id":9236700,"accession":"0001144204-14-075196","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-9","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550219.0,"shares_display":"550,219","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":19883944.0,"shares_owned_after_display":"19,883,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902762,"accession":"0001144204-14-075189","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-9","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550219.0,"shares_display":"550,219","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":19883944.0,"shares_owned_after_display":"19,883,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236706,"accession":"0001144204-14-075196","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-8","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":796879.0,"shares_display":"796,879","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":19333725.0,"shares_owned_after_display":"19,333,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902758,"accession":"0001144204-14-075189","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-8","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":796879.0,"shares_display":"796,879","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":19333725.0,"shares_owned_after_display":"19,333,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236702,"accession":"0001144204-14-075196","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-7","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":562500.0,"shares_display":"562,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":18536847.0,"shares_owned_after_display":"18,536,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-30","filed_date":"2014-12-22","scope":"insider"},{"id":6902755,"accession":"0001144204-14-075189","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-7","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":562500.0,"shares_display":"562,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":18536847.0,"shares_owned_after_display":"18,536,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-30","filed_date":"2014-12-19","scope":"insider"},{"id":9236698,"accession":"0001144204-14-075196","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-6","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":385320.0,"shares_display":"385,320","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17974347.0,"shares_owned_after_display":"17,974,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902751,"accession":"0001144204-14-075189","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-6","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":385320.0,"shares_display":"385,320","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17974347.0,"shares_owned_after_display":"17,974,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236697,"accession":"0001144204-14-075196","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-5","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":341971.0,"shares_display":"341,971","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17589027.0,"shares_owned_after_display":"17,589,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902748,"accession":"0001144204-14-075189","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-5","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":341971.0,"shares_display":"341,971","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17589027.0,"shares_owned_after_display":"17,589,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236696,"accession":"0001144204-14-075196","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-4","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":289531.0,"shares_display":"289,531","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17247056.0,"shares_owned_after_display":"17,247,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902746,"accession":"0001144204-14-075189","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-4","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":289531.0,"shares_display":"289,531","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17247056.0,"shares_owned_after_display":"17,247,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236705,"accession":"0001144204-14-075196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-2","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133333.0,"shares_display":"133,333","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":485332.12,"total_display":"485,332.12","shares_owned_after":17077895.0,"shares_owned_after_display":"17,077,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-12-22","scope":"insider"},{"id":9236695,"accession":"0001144204-14-075196","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-3","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120370.0,"shares_display":"120,370","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":438146.8,"total_display":"438,146.80","shares_owned_after":16957525.0,"shares_owned_after_display":"16,957,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-12-22","scope":"insider"},{"id":6902742,"accession":"0001144204-14-075189","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-3","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133333.0,"shares_display":"133,333","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":485332.12,"total_display":"485,332.12","shares_owned_after":17077895.0,"shares_owned_after_display":"17,077,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-12-19","scope":"insider"},{"id":6902738,"accession":"0001144204-14-075189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-2","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120370.0,"shares_display":"120,370","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":438146.8,"total_display":"438,146.80","shares_owned_after":16957525.0,"shares_owned_after_display":"16,957,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-12-19","scope":"insider"},{"id":9236701,"accession":"0001144204-14-075196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-075196","line_url":"/filing/0001144204-14-075196#line-1","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":389611.0,"shares_display":"389,611","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17211228.0,"shares_owned_after_display":"17,211,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902734,"accession":"0001144204-14-075189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-075189","line_url":"/filing/0001144204-14-075189#line-1","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Powers Linda F; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":389611.0,"shares_display":"389,611","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17211228.0,"shares_owned_after_display":"17,211,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236688,"accession":"0001144204-14-075195","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-9","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79630.0,"shares_display":"79,630","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":246056.7,"total_display":"246,056.70","shares_owned_after":16821617.0,"shares_owned_after_display":"16,821,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-08","filed_date":"2014-12-22","scope":"insider"},{"id":6902730,"accession":"0001144204-14-075188","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-10","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79630.0,"shares_display":"79,630","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":246056.7,"total_display":"246,056.70","shares_owned_after":16821617.0,"shares_owned_after_display":"16,821,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-08","filed_date":"2014-12-19","scope":"insider"},{"id":9236689,"accession":"0001144204-14-075195","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-8","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132540.0,"shares_display":"132,540","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":409548.6,"total_display":"409,548.60","shares_owned_after":16901247.0,"shares_owned_after_display":"16,901,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-12-22","scope":"insider"},{"id":6902727,"accession":"0001144204-14-075188","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-9","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132540.0,"shares_display":"132,540","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":409548.6,"total_display":"409,548.60","shares_owned_after":16901247.0,"shares_owned_after_display":"16,901,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-12-19","scope":"insider"},{"id":9236690,"accession":"0001144204-14-075195","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-7","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233344.0,"shares_display":"233,344","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":749034.24,"total_display":"749,034.24","shares_owned_after":17033787.0,"shares_owned_after_display":"17,033,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-12-22","scope":"insider"},{"id":6902723,"accession":"0001144204-14-075188","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-8","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233344.0,"shares_display":"233,344","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":749034.24,"total_display":"749,034.24","shares_owned_after":17033787.0,"shares_owned_after_display":"17,033,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-12-19","scope":"insider"},{"id":9236692,"accession":"0001144204-14-075195","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-5","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":16980076.0,"shares_owned_after_display":"16,980,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-01","filed_date":"2014-12-22","scope":"insider"},{"id":9236691,"accession":"0001144204-14-075195","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-6","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":287055.0,"shares_display":"287,055","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17267131.0,"shares_owned_after_display":"17,267,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902721,"accession":"0001144204-14-075188","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-7","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":16980076.0,"shares_owned_after_display":"16,980,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-01","filed_date":"2014-12-19","scope":"insider"},{"id":6902717,"accession":"0001144204-14-075188","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-6","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":287055.0,"shares_display":"287,055","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":17267131.0,"shares_owned_after_display":"17,267,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236693,"accession":"0001144204-14-075195","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-4","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233344.0,"shares_display":"233,344","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":749034.24,"total_display":"749,034.24","shares_owned_after":16480076.0,"shares_owned_after_display":"16,480,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-31","filed_date":"2014-12-22","scope":"insider"},{"id":6902713,"accession":"0001144204-14-075188","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-5","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233344.0,"shares_display":"233,344","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":749034.24,"total_display":"749,034.24","shares_owned_after":16480076.0,"shares_owned_after_display":"16,480,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-31","filed_date":"2014-12-19","scope":"insider"},{"id":9236694,"accession":"0001144204-14-075195","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-3","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5101366.0,"shares_display":"5,101,366","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":16713420.0,"shares_owned_after_display":"16,713,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-17","filed_date":"2014-12-22","scope":"insider"},{"id":6902710,"accession":"0001144204-14-075188","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-4","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5101366.0,"shares_display":"5,101,366","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":16713420.0,"shares_owned_after_display":"16,713,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-17","filed_date":"2014-12-19","scope":"insider"},{"id":9236686,"accession":"0001144204-14-075195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-2","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":238248.0,"shares_display":"238,248","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":11612054.0,"shares_owned_after_display":"11,612,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902706,"accession":"0001144204-14-075188","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-3","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":238248.0,"shares_display":"238,248","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":11612054.0,"shares_owned_after_display":"11,612,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-01","filed_date":"2014-12-19","scope":"insider"},{"id":9236687,"accession":"0001144204-14-075195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-075195","line_url":"/filing/0001144204-14-075195#line-1","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Powers Linda F; Toucan Capital Fund III, L.P.; Toucan General II, LLC; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277199.0,"shares_display":"277,199","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":10043749.0,"shares_owned_after_display":"10,043,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-01","filed_date":"2014-12-22","scope":"insider"},{"id":6902701,"accession":"0001144204-14-075188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-075188","line_url":"/filing/0001144204-14-075188#line-1","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Hemphill Robert F Jr.; Powers Linda F; Toucan Partners, LLC; Cognate Bioservices, Inc.; Toucan General II, LLC; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277199.0,"shares_display":"277,199","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":10043749.0,"shares_owned_after_display":"10,043,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-01","filed_date":"2014-12-19","scope":"insider"},{"id":6251407,"accession":"0001144204-14-075186","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-075186","line_url":"/filing/0001144204-14-075186#line-10","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Powers Linda F; Toucan General II, LLC; Toucan Capital Fund III, L.P.; Hemphill Robert F Jr.; Cognate Bioservices, Inc.; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":257439.0,"shares_display":"257,439","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":9766550.0,"shares_owned_after_display":"9,766,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2014-12-19","scope":"insider"},{"id":6251403,"accession":"0001144204-14-075186","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-14-075186","line_url":"/filing/0001144204-14-075186#line-9","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Powers Linda F; Toucan General II, LLC; Toucan Capital Fund III, L.P.; Hemphill Robert F Jr.; Cognate Bioservices, Inc.; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":223042.0,"shares_display":"223,042","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":9509111.0,"shares_owned_after_display":"9,509,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-31","filed_date":"2014-12-19","scope":"insider"},{"id":6251400,"accession":"0001144204-14-075186","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-075186","line_url":"/filing/0001144204-14-075186#line-8","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Powers Linda F; Toucan General II, LLC; Toucan Capital Fund III, L.P.; Hemphill Robert F Jr.; Cognate Bioservices, Inc.; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2902072.0,"shares_display":"2,902,072","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":11608288.0,"total_display":"11,608,288.00","shares_owned_after":9286069.0,"shares_owned_after_display":"9,286,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-31","filed_date":"2014-12-19","scope":"insider"},{"id":6251397,"accession":"0001144204-14-075186","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-14-075186","line_url":"/filing/0001144204-14-075186#line-7","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Powers Linda F; Toucan General II, LLC; Toucan Capital Fund III, L.P.; Hemphill Robert F Jr.; Cognate Bioservices, Inc.; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":749339.0,"shares_display":"749,339","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":6383997.0,"shares_owned_after_display":"6,383,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-30","filed_date":"2014-12-19","scope":"insider"},{"id":6251391,"accession":"0001144204-14-075186","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-14-075186","line_url":"/filing/0001144204-14-075186#line-5","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Powers Linda F; Toucan General II, LLC; Toucan Capital Fund III, L.P.; Hemphill Robert F Jr.; Cognate Bioservices, Inc.; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2272907.0,"shares_display":"2,272,907","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":5147907.0,"shares_owned_after_display":"5,147,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2014-12-19","scope":"insider"},{"id":6251388,"accession":"0001144204-14-075186","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-075186","line_url":"/filing/0001144204-14-075186#line-4","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Powers Linda F; Toucan General II, LLC; Toucan Capital Fund III, L.P.; Hemphill Robert F Jr.; Cognate Bioservices, Inc.; Toucan Partners, LLC","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":486751.0,"shares_display":"486,751","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":5634658.0,"shares_owned_after_display":"5,634,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2014-12-19","scope":"insider"},{"id":6826775,"accession":"0001144204-14-075185","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001144204-14-075185","line_url":"/filing/0001144204-14-075185#line-11","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Powers Linda F; Toucan General II, LLC; Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":860000.0,"shares_display":"860,000","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":928800.0,"total_display":"928,800.00","shares_owned_after":7088246.0,"shares_owned_after_display":"7,088,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-02","filed_date":"2014-12-19","scope":"insider"},{"id":6826760,"accession":"0001144204-14-075185","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-075185","line_url":"/filing/0001144204-14-075185#line-6","is_derivative":false,"issuer_cik":"0001072379","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","issuer_ticker":"NWBO","issuer_name_source":null,"issuer_url":"/issuer/0001072379","owner_cik":null,"owner_name":"Toucan Partners, LLC; Powers Linda F; Toucan General II, LLC; Cognate Bioservices, Inc.; Hemphill Robert F Jr.; Toucan Capital Fund III, L.P.","owner_url":null,"role":"Director, Officer (Chairperson, CEO), Ten percent owner","officer_title":"Chairperson, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8466.0,"shares_display":"8,466","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":1693.2,"total_display":"1,693.20","shares_owned_after":10318246.0,"shares_owned_after_display":"10,318,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-07-31","filed_date":"2014-12-19","scope":"insider"}],"next_cursor":"2010-07-31|6826760","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001072379","name":"NORTHWEST BIOTHERAPEUTICS INC","url":"/issuer/0001072379","role":"Ten percent owner","n_filings":6,"first_seen":"2014-12-19","last_seen":"2014-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001344441","retrieved_at":"2026-08-21T18:02:04+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}